Yeah 100% this is what I am interested in also and I would like some commentary on. iMed are the first commercial partner it is important that the company report on the revenue, not just the success of the product.
Ann: Quarterly Activity Report and Appendix 4C for Q2 FY2022, page-5
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.8¢ |
Change
-0.003(0.47%) |
Mkt cap ! $213.4M | |||
| Open | High | Low | Value | Volume |
| 53.0¢ | 53.0¢ | 51.5¢ | $34.65K | 65.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 926 | 52.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.0¢ | 71509 | 6 |
View Market Depth
| Last trade - 12.22pm 01/11/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |